These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 6590287
1. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis]. Heptner G, Domschke S, Krapf F, Schneider MU, Iro H, Domschke W. Dtsch Med Wochenschr; 1984 Aug 31; 109(35):1309-12. PubMed ID: 6590287 [Abstract] [Full Text] [Related]
2. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis]. Lorenz M, Happ J, Hottenrott C, Maul FD, Baum RP, Hör G, Encke A. Nuklearmedizin; 1986 Feb 31; 25(1):9-14. PubMed ID: 3459133 [Abstract] [Full Text] [Related]
3. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9. Quentmeier A, Schlag P, Geisen HP, Schmidt-Gayk H. Eur J Surg Oncol; 1987 Jun 31; 13(3):197-201. PubMed ID: 3474158 [Abstract] [Full Text] [Related]
4. Clinical evaluation of M43: a novel cancer-associated mucin epitope. Goodgame R, Kiefe C, Rose E, Sutton F, Brown J, Alpert E. Cancer Res; 1993 Jun 15; 53(12):2803-9. PubMed ID: 7684947 [Abstract] [Full Text] [Related]
5. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas. Cangemi V, Volpino P, Fiori E, Giammarco A, Piat G. J Nucl Med Allied Sci; 1987 Jun 15; 31(2):189-93. PubMed ID: 3476692 [No Abstract] [Full Text] [Related]
10. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma]. Wu J, Yu H, Shao Y. Zhonghua Zhong Liu Za Zhi; 1995 Nov 15; 17(6):438-40. PubMed ID: 8697997 [Abstract] [Full Text] [Related]
11. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer]. Yu BM. Zhonghua Wai Ke Za Zhi; 1992 Dec 15; 30(12):707-9, 777. PubMed ID: 1339738 [Abstract] [Full Text] [Related]
14. Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon. von Kleist S, Hesse Y, Kananeeh H. Anticancer Res; 1996 Dec 15; 16(4B):2325-31. PubMed ID: 8694564 [Abstract] [Full Text] [Related]
15. Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer. Eskelinen M, Pasanen P, Kulju A, Janatuinen E, Miettinen P, Poikolainen E, Tarvainen R, Nuutinen P, Pääkkönen M, Alhava E. Anticancer Res; 1994 Dec 15; 14(3B):1427-32. PubMed ID: 8067718 [Abstract] [Full Text] [Related]
17. Carcinoembryonic antigen (CEA) and gastrointestinal cancer associated antigen CA 19-9 in bronchioloalveolar carcinomas and pulmonary adenocarcinomas. Heikkilä L, Suomalainen RJ, Lindgren J, Jalanko H, Harjula A, Mattila S. Ann Chir Gynaecol; 1986 Dec 15; 75(5):260-5. PubMed ID: 3030184 [Abstract] [Full Text] [Related]
19. Small intestinal mucin antigen (SIMA); a novel tumour marker in colorectal cancer? Eskelinen M, Pasanen P, Janatuinen E, Pettersson N, Linnane A, Alhava E. Anticancer Res; 1995 Dec 15; 15(5B):2351-6. PubMed ID: 8572651 [Abstract] [Full Text] [Related]
20. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D, Nürnberg R, Bahlo M, Klapdor R. Anticancer Res; 1999 Dec 15; 19(4A):2443-50. PubMed ID: 10470173 [Abstract] [Full Text] [Related] Page: [Next] [New Search]